Section archive

Healthcare

All desks 26231 Book Reviews Breaking News Business Consumer Digital Education Entertainment Evening Roundup Healthcare Military Morning Briefing Policy Politics Tech Travel US World

Healthcare

CDC Recommends Pfizer COVID-19 Boosters for Adolescents 12 to 17 as Omicron Drives Record U.S. Infections

The CDC now recommends Pfizer-BioNTech booster doses for adolescents ages 12 to 17, five months after their primary series, as Omicron rapidly expands across the United States.

Healthcare

CDC Cuts COVID-19 Isolation From 10 Days to 5 as Omicron Surge Strains Workplaces and Hospitals

Jan 1, 2022

Healthcare

FDA Authorizes Pfizer’s Paxlovid and Merck’s Molnupiravir, Adding Two At-Home Antiviral Pills as Omicron Surges

Dec 25, 2021

Healthcare

U.S. COVID-19 Death Toll Passes 800,000 as Cases and Hospitalizations Rise Into Winter

Dec 18, 2021

Healthcare

FDA and CDC Open Pfizer Boosters to 16- and 17-Year-Olds as Omicron Raises Pressure to Strengthen Immunity

Dec 11, 2021

Healthcare

First U.S. Omicron Case Confirmed in California as Officials Tighten Travel Testing and Race to Assess New Variant

Dec 4, 2021

Healthcare

WHO Names Omicron a Variant of Concern as Heavily Mutated Coronavirus Strain Triggers Global Surveillance and Travel Measures

Nov 27, 2021

Healthcare

U.S. Opens Pfizer and Moderna COVID-19 Boosters to All Adults as CDC Endorses Expanded Eligibility Before Holidays

Nov 20, 2021

Healthcare

Medicare Part B Premium Jumps $21.60 to $170.10 for 2022 as CMS Builds Reserve for Aduhelm Uncertainty

Nov 13, 2021

Healthcare

CDC Recommends Pfizer COVID-19 Vaccine for 28 Million Children Ages 5 to 11, Opening Pediatric Campaign

Nov 6, 2021

Healthcare

FDA Authorizes Pfizer COVID-19 Vaccine for 28 Million U.S. Children Ages 5 to 11

Oct 30, 2021

Healthcare

CDC Backs Moderna and Johnson & Johnson Boosters and Allows Mix-and-Match Doses Across All Three U.S. Vaccines

Oct 23, 2021

Healthcare

FDA Advisers Back Moderna and Johnson & Johnson Boosters, Moving U.S. Toward a Three-Vaccine Booster Strategy

Oct 16, 2021

Healthcare

Pfizer Seeks U.S. Authorization for COVID-19 Vaccine in 28 Million Children Ages 5 to 11

Oct 9, 2021

Healthcare

Merck Says Oral COVID-19 Drug Cut Hospitalization or Death by About 50% in Interim Phase 3 Trial

Oct 2, 2021

Healthcare

CDC Clears Pfizer Boosters for Seniors, High-Risk Adults and Workers With Frequent COVID-19 Exposure

Sep 25, 2021

Healthcare

FDA Advisers Reject Pfizer Boosters for Everyone 16 and Older, Back Third Doses for Seniors and High-Risk Adults

Sep 18, 2021

Healthcare

CDC Data Show Unvaccinated Adults Face About 10 Times the Hospitalization Risk and 11 Times the Death Risk During Delta

Sep 11, 2021

215 stories